Biniam Kidane: The IASLC Grant is Pivotal Step Toward Advancing My Translational Lung Cancer Research
This grant will provide critical seed funding to build on and validate the promising results my translational research team generated in my early career. With prior early-career support, we developed both human and experimental in vivo models to study treatment-induced inflammation and its role in early cancer recurrence. My goal is to expand this work into a large, multi-center translational study using an iterative bench-to-bedside-to-bench approach. However, to reach that stage, we first need transitional funding to refine and confirm our models as essential groundwork. The IASLC grant is a pivotal step toward bringing this vision to reality.
Qualifications
- Completed medical degree and residency in oncology
- PhD in relevant field (e.g., molecular biology, immunology)
- Experience in translational research
- Strong publication record in oncology journals
Responsibilities
- Develop and validate new models for studying treatment-induced inflammation
- Collaborate with multidisciplinary teams to design and execute translational studies
- Contribute to the refinement and confirmation of existing models
- Write and publish research papers in high-impact oncology journals
Benefits
- Potential for significant impact on understanding and treating cancer
- Opportunity to lead a large, multi-center translational study
- Access to resources and expertise within the IASLC network
Schedule
- Grant award expected to be announced in [Month] [Year]
- Study initiation planned for [Month] [Year]
- Research completion anticipated by [Month] [Year]
Pay
- Salary range: [Amount] - [Amount]
- Benefits package includes health insurance, retirement plan, and professional development opportunities
The IASLC Mid-Career Grant applications are now open. Ready to take your research to the next level?